Hi, I am very new so apologies if this is a naive question. I have a small position in NVO that I would like to add to in near future. Company is well managed, expanding its manufacturing capacity to meet demand in a growing market which is all positive. Also new, even more effective than Ozempic oral pill in the pipeline. Some consider stock overpriced at current level but when compared to LLY it seems reasonable. The main thing that prevents me from buying is a sell off by insiders in the recent months. Nobody's buying, quite a few sold. Would this be a valid reason to hold on and wait for earnings? I feel like I might miss out considering all other known factors are looking good.
Leave a Reply